acetylcysteine has been researched along with Coronary Artery Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergo, RR; Berwanger, O; Buehler, A; Cantarelli, MJ; Carvalho, VO; Castello-Júnior, HJ; Cavalcanti, AB; da Motta, PA; Kodama, A; Mangione, JA; Nunes, PM; São Thiago, LE; Sousa, AM; Sousa, JE; Victor, E | 1 |
| Akca, B; Battaloglu, B; Colak, MC; Disli, OM; Erdil, F; Erdil, N; Eroglu, T; Yetkin, O | 1 |
| Bayar, MK; Burma, O; Halifeoğlu, I; Köksal, H; Rahman, A | 1 |
| Alves, L; Bassetto, S; Evora, PR; Origuela, EA; Rodrigues, AJ; Scorzoni Filho, A; Vicente, WV | 1 |
| Berwanger, O; Gurm, HS; Moscucci, M; Nallamothu, BK; Schreiber, T; Share, D; Smith, DE | 1 |
| Aittomäki, J; Karhunen, J; Nemlander, A; Rämö, OJ; Salo, J; Vento, AE | 1 |
| Bloch, W; Fischer, UM; Geissler, HJ; Huebner, A; Mehlhorn, U; Tossios, P | 1 |
| Airoldi, F; Balestrieri, P; Briguori, C; Castelli, A; Colombo, A; Focaccio, A; Golia, B; Lepore, S; Librera, M; Paolo Elia, P; Ricciardelli, B; Riviezzo, G; Scarpato, P; Violante, A | 1 |
| Ambrosini, V; Bolognese, L; Bongo, AS; Gaglione, A; Galassi, AR; Marzocchi, A; Petronio, AS; Savonitto, S; Tolaro, S | 1 |
| Alver, A; Kalyoncu, NI; Karahan, SC; Koramaz, I; Ozcan, F; Pulathan, Z; Usta, S; Yaris, E | 1 |
| Aka, SA; Aykaç, Z; Orhan, G; Sargin, M; Senay, S; Yalçin, AS; Yapici, N; Yuksel, M | 1 |
| Chen, JW; Chen, YH; Lin, SJ | 1 |
| Bolca, O; Cakmak, N; Nurkalem, Z; Onturk, E; Sahin, S; Sayar, N; Tangurek, B; Yilmaz, H; Yilmaz, M | 1 |
| Andrews, NP; Prasad, A; Quyyumi, AA | 1 |
10 trial(s) available for acetylcysteine and Coronary Artery Disease
| Article | Year |
|---|---|
Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Placebos; Risk Factors; Treatment Failure | 2013 |
The effects of N-acetylcysteine on pulmonary functions in patients undergoing on-pump coronary artery surgery: a double blind placebo controlled study.
Topics: Acetylcysteine; Aged; Blood Gas Analysis; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lung Diseases; Male; Middle Aged; Prospective Studies; Respiratory Function Tests | 2016 |
The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
Topics: Acetylcysteine; Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Free Radical Scavengers; Heart Arrest, Induced; Humans; Inflammation Mediators; Male; Middle Aged; Myocardial Reperfusion Injury; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Treatment Outcome | 2008 |
Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress.
Topics: Acetylcysteine; Combined Modality Therapy; Coronary Artery Disease; Endothelium, Vascular; Female; Free Radical Scavengers; Heart Arrest, Induced; Humans; Male; Middle Aged; Oxidative Stress; Treatment Outcome; Vasoconstriction | 2009 |
N-acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients.
Topics: Acetylcysteine; Blood Chemical Analysis; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Artery Disease; Energy Metabolism; Free Radical Scavengers; Hemodynamics; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Peroxidase; Prospective Studies; Treatment Outcome; Ventricular Function | 2003 |
Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery.
Topics: Acetylcysteine; Aged; Apoptosis; Cardiopulmonary Bypass; Caspase 3; Caspase 7; Caspases; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Enzyme Activation; Female; Free Radical Scavengers; Heart Rate; Humans; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Treatment Outcome; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2004 |
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Dopamine Agonists; Drug Administration Schedule; Female; Fenoldopam; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male | 2004 |
Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
Topics: Acetylcysteine; Coronary Artery Bypass; Coronary Artery Disease; Female; Free Radical Scavengers; Heart Arrest, Induced; Hemodynamics; Humans; Hypothermia, Induced; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Reperfusion Injury; Treatment Outcome; Troponin I | 2006 |
Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery.
Topics: Acetylcysteine; Acridines; Aged; Biomarkers; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Indicators and Reagents; Inflammation Mediators; Luminescent Measurements; Luminol; Male; Middle Aged; Myocardial Reperfusion Injury; Oxidative Stress; Reactive Oxygen Species; Research Design; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Topics: Acetylcysteine; Administration, Oral; Aged; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2007 |
4 other study(ies) available for acetylcysteine and Coronary Artery Disease
| Article | Year |
|---|---|
Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Cooperative Behavior; Coronary Artery Disease; Female; Free Radical Scavengers; Glomerular Filtration Rate; Health Status Indicators; Humans; Male; Michigan; Middle Aged; Practice Patterns, Physicians'; Propensity Score; Prospective Studies; Registries; Statistics as Topic; Treatment Outcome | 2012 |
Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Utilization Review; Female; Health Care Surveys; Heparin; Humans; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Pyridines; Registries; Ticlopidine | 2005 |
Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-alpha-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways.
Topics: Acetylcysteine; Animals; Cell Adhesion; Cells, Cultured; Coronary Artery Disease; Endothelium, Vascular; Humans; I-kappa B Proteins; Lipoproteins, LDL; Mice; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Oxidative Stress; Superoxides; Tumor Necrosis Factor-alpha | 2006 |
N-acetylcysteine improves coronary and peripheral vascular function.
Topics: Acetylcysteine; Adult; Coronary Artery Disease; Coronary Circulation; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Female; Femoral Artery; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Nitroprusside; Vasodilation | 2001 |